Professional Documents
Culture Documents
DOI 10.1007/s00455-007-9113-4
ORIGINAL ARTICLE
123
137
Methods
The study was a prospective repeated-measures design.
Two groups were studied: one with idiopathic Parkinsons
disease and a healthy, similarly aged control group. Using
historical data on the proportions of swallows occurring
during exhalation for normal and neurologically impaired
participants [36] (an alpha level of 0.05, and power of 0.8),
it was determined that 25 subjects per group would be
required to detect a moderate effect. This study was
approved by the VA Pittsburgh Health Systems Institutional Review Board and all subjects gave written consent
prior to screening and participation.
The mean age of the 25 volunteers with IPD was 71
years (range = 5384, SD = 9.86). All participants were
male because they were recruited from the largely male
veteran population. Idiopathic IPD was diagnosed and
rated as stage 2 or 3 on the Hoehn & Yahr disability scale
by a board-certified neurologist. The average Hoehn
&Yahr rating for the group was 2.4. None of the participants had a previous history of other neurologic disease,
stroke, head and neck cancer, lung cancer, or chronic
obstructive pulmonary disease. In addition, each had to
receive the following individual scores on the Unified
Parkinson Disease Rating Scale (UPDRS): Intellectual
Impairment score of 0 (normal), Thought Disorder score of
2 or less, Depression score of 2 or less, Motivation/Initiative score of 3 or less, Speech score of 2 or less, Salivation
score of 2 or less, Swallowing score of 3 or less. Table 1
shows the number of participants that received each
acceptable score. Oropharyngeal swallowing function was
not instrumentally assessed, but at the time of this study all
participants were receiving 100% of their nutrition and
hydration orally and all stated that semisolids like pudding
and soft solids such as sugar cookies were part of their
daily diet. In addition, the delayed/immediate recall ratio
on the Story Retelling-Immediate/Story RetellingDelayed
subtests of the Arizona Battery for Communicative Disorders of Dementia was used to rule out dementia [37].
This ratio, which compares the amount of information
recalled in an immediate condition compared to the amount
123
138
No.
subjects
Intellectual impairment
0 (normal)
Thought disorder
0 (normal)
25
15
1 (vivid dreaming)
Depression
0 (normal)
1 (periods of sadness/guilt greater than normal)
24
1
Motivation/Initiative
0 (normal)
20
Speech
0 (normal)
14
Salivation
0 (normal)
1 (slight but definite excess of saliva in mouth;
may have nighttime drooling)
2 (moderately excessive saliva;
may have minimal drooling)
Swallowing
0 (normal)
1 (rare choking)
9
12
4
20
2
2 (occasional choking)
123
Data Analysis
Blinding procedures were used during the determination of
respiratory characteristics surrounding each swallow.
139
Results
In the control group, the proportion of swallows of both
consistencies that occurred during exhalation and were
followed by exhalation was consistent with previous
reports [30, 42]. Logistic regression analysis showed that,
when compared to the healthy controls, the IPD group
swallowed significantly more often during inhalation,
regardless of whether a semisolid (pudding) or solid
(cookie) was consumed. The IPD participants also exhibited significantly more postswallow inhalation for both
consistencies. In addition, those in the IPD group swallowed both consistencies at low tidal volume significantly
more frequently than those in the control group. Tables 24
are the statistical tables from the analysis and Fig. 2 is a
graphic display of the data.
123
140
Healthy Cookie
4/214
IPD
29/211
Cookie
Healthy Pudding
22/230
IPD
39/235
Pudding
p Value
8.37
8.9, 24.2
0.0001
1.9
Healthy Cookie
20/214
IPD
52/210
Cookie
Healthy Pudding
17/230
IPD
60/235
Pudding
Discussion
p Value
3.2
4.30
Healthy Cookie
IPD
Cookie
17/214
54/211
Healthy Pudding
16/230
IPD
54/235
Pudding
p Value
2.4
4.0
Percentage of swallow
25
20
15
10
0
Cookie
Pudding
123
Cookie
Pudding
Cookie
Pudding
141
Statistic
Exhale DDA
Inhale DDA
p Value
Healthy
347
26
0.025
Mean, SD
649, 133
887, 274
Median
670
801
Q1, Q3
609, 748
744, 921
Min, Max
377, 1357
576, 1744
Statistic
Exhale DDA
Inhale DDA
p Value
IPD
272
49
0.308
Mean, SD
643, 133
665, 182
Median
624
609
Q1, Q3
558, 692
545, 705
Min, Max
409, 1300
417, 1325
900
Inhalation
800
700
Exhalation
Exhalation
Inhalation
600
500
400
300
200
100
0
Healthy
Parkinson's
123
142
123
Limitations
The primary limitation of this study is that we relied on
chart review and the IPD volunteers perception of their
swallowing and pulmonary function. Therefore, we cannot say with certainty if any of the IPD participants had
subclinical dysphagia or pulmonary disease. For this
initial study we wanted to first determine if impaired
breathing/swallowing coordination was present in a typical sample of clinic patients. Another potential criticism
is that we did not quantify tidal breathing using a nasal
mask. However, the main objective was to create as
natural an environment as possible so that we could
observe spontaneous behaviors and a nasal mask could
influence spontaneity.
Conclusion
Accurate coordination between breathing and swallowing
could be the key to swallowing safety in IPD because
sufficient subglottic air pressure is easiest to generate at
higher tidal volumes. Furthermore, exhalatory airflow after
the swallow can serve as an airway-clearing mechanism if
any material entered the airway while swallowing [31].
Impaired coordination between breathing and swallowing
in IPD patients is likely to have a negative effect on
swallowing performance and can help to explain the high
prevalence of dysphagia that occurs at any point during the
disease, regardless of severity. This rationale can also
partially explain why anti-Parkinson drugs do not consistently improve swallowing function or prevent the
development of oropharyngeal dysphagia.
143
Appendix A
Screening Questionnaire for Interested Individuals
Subject ID_________
What happens when you drink thin liquids such as water, coffee, tea or juice?
What happens when you eat solid food?
Are there any foods that you avoid? If so, why?
Do you have any difficulty swallowing?
Have you had any difficulty swallowing in the last 6 months other than
a sore throat?
Have you ever been diagnosed with a stroke or a ministroke?
Have you ever thought that you had stroke or a ministroke?
Have you ever had a serious head injury that required a hospital stay?
Have you ever been diagnosed with a progressive neurological disease
such as Parkinsons disease, multiple sclerosis (MS), ALS (Lou Gherigs
disease) or myasthenia gravis?
Do you think that you have a progressive neurological disease such as
Parkinsons disease, multiple sclerosis (MS), ALS (Lou Gherigs disease)
or myasthenia gravis?
Have you ever been diagnosed with a muscle disease such as polymyositis,
sarcoidosis, myotonic dystrophy, or oculopharyngeal dystrophy?
Do you think that you might have a muscle disease?
Have you ever been diagnosed with oral or pharyngeal (throat) cancer?
Have you ever had an oral or throat tumor removed?
Have you ever had any surgery to your tongue or to the inside or outside
of your neck?
Have you ever been diagnosed with chronic obstructive pulmonary disease
(COPD) or emphysema?
Do you think that you might have chronic obstructive pulmonary disease
(COPD) or emphysema?
Do you have any difficulty breathing?
Yes
No
Yes
Yes
Yes
Yes
No
No
No
No
Yes
No
Yes
No
Yes
Yes
Yes
Yes
No
No
No
No
Yes
No
Yes
No
Yes
Yes
No
No
References
1. Tanner CM, Ben-Shlomo Y. Epidemiology of Parkinsons disease. Adv Neurol 1999;80:153159.
2. Wermuth L, Stenager EN, Stenager E, Boldsen J. Mortality in
patients with Parkinsons disease. Acta Neurol Scand
1995;92:5558.
3. DAmelio M, Ragonese P, Morgante L, Reggio A, Callari G,
Salemi G, Savettieri G. Long-term survival of Parkinsons disease: a population-based study. J Neurol 2006;253:3337.
4. Schupbach MW, Welter ML, Bonnet AM, Elbaz A, Grossardt
BR, Mesnage V, Houeto JL, Maltete D, Mallet L, Rocca WA,
Mallet A, Agid Y. Mortality in patients with Parkinsons disease
treated by stimulation of the subthalamic nucleus. Mov Disord
2007;22:257261.
5. Fall PA, Saleh A, Fredrickson M, Olsson JE, Granerus AK.
Survival time, mortality, and cause of death in elderly patients
with Parkinsons disease: a 9-year follow-up. Mov Disord
2003;18:13121316.
6. Morgante L, Salemi G, Meneghini F, Di Rosa AE, Epifanio A,
Grigoletto F, Ragonese P, Patti F, Reggio A, Di Perri R, Savettieri G. Parkinson disease survival: a population-based study.
Arch Neurol 2000;57:507512.
7. Bird MR, Woodward MC, Gibson EM, Phyland DJ, Fonda D.
Asymptomatic swallowing disorders in elderly patients with
8.
9.
10.
11.
12.
13.
14.
15.
Parkinsons disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients. Age Ageing
1994;23:251254.
Stroudley J, Walsh M. Radiological assessment of dysphagia in
Parkinsons disease. Br J Radiol 1991;64:890893.
Potulska A, Friedman A, Krolicki L, Jedrzejowski M, Spychala
A. [Swallowing disorders in Parkinsons disease]. Neurol Neurochir Pol 2002;36:449456.
Miller N, Noble E, Jones D, Burn D. Hard to swallow: dysphagia
in Parkinsons disease. Age Ageing 2006;35:614618.
Ali GN, Wallace KL, Schwartz R, DeCarle DJ, Zagami AS, Cook
IJ. Mechanisms of oral-pharyngeal dysphagia in patients with
Parkinsons disease. Gastroenterology 1996;110:383392.
Monte FS, da Silva-Junior FP, Braga-Neto P, Nobre e Souza MA,
Sales de Bruin VM. Swallowing abnormalities and dyskinesia in
Parkinsons disease. Mov Disord 2005;20:457462.
Nilsson H, Ekberg O, Bulow M, Hindfelt B. Assessment of respiration during video fluoroscopy of dysphagic patients. Acad
Radiol 1997;4:503507.
Clarke CE, Gullaksen E, Macdonald S, Lowe F. Referral criteria for
speech and language therapy assessment of dysphagia caused by
idiopathic Parkinsons disease. Acta Neurol Scand 1998;97:2735.
Hunter PC, Crameri J, Austin S, Woodward MC, Hughes AJ.
Response of parkinsonian swallowing dysfunction to dopaminergic
stimulation. J Neurol Neurosurg Psychiatry 1997;63:579583.
123
144
16. Ertekin C, Tarlaci S, Aydogdu I, Kiylioglu N, Yuceyar N, Turman AB, Secil Y, Esmeli F. Electrophysiological evaluation of
pharyngeal phase of swallowing in patients with Parkinsons
disease. Mov Disord 2002;17:942949.
17. Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS. Swallowing abnormalities and their response to treatment in
Parkinsons disease. Neurology 1989;39:13091314.
18. Duff J, Sime E. Surgical interventions in the treatment of Parkinsons disease (PD) and essential tremor (ET): medial
pallidotomy in PD and chronic deep brain stimulation (DBS) in
PD and ET. Axone 1997;18:8589.
19. Chou KL, Forman MS, Trojanowski JQ, Hurtig HI, Baltuch GH.
Subthalamic nucleus deep brain stimulation in a patient with
levodopa-responsive multiple system atrophy. Case report. J
Neurosurg 2004;100:553556.
20. Okun MS, Stover NP, Subramanian T, Gearing M, Wainer BH,
Holder CA, Watts RL, Juncos JL, Freeman A, Evatt ML, Schuele
SU, Vitek JL, DeLong MR. Complications of gamma knife surgery for Parkinson disease. Arch Neurol 2001;58:19952002.
21. Esselink RA, de Bie RM, de Haan RJ, Steur EN, Beute GN,
Portman AT, Schuurman PR, Bosch DA, Speelman JD. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation
in Parkinsons disease: one year follow-up of a randomised
observer-blind multi centre trial. Acta Neurochir (Wien)
2006;148:12471255.
22. Feroah TR, Forster HV, Fuentes CG, Lang IM, Beste D, Martino
P, Pan L, Rice T. Effects of spontaneous swallows on breathing in
awake goats. J Appl Physiol 2002;92:19231935.
23. Vercueil L, Linard JP, Wuyam B, Pollak P, Benchetrit G.
Breathing pattern in patients with Parkinsons disease. Respir
Physiol 1999;118:163172.
24. Pal PK, Sathyaprabha TN, Tuhina P, Thennarasu K. Pattern of
subclinical pulmonary dysfunctions in Parkinsons disease and
the effect of levodopa. Mov Disord 2007;22:420424.
25. de Bruin PF, de Bruin VM, Lees AJ, Pride NB. Effects of
treatment on airway dynamics and respiratory muscle strength in
Parkinsons disease. Am Rev Respir Dis 1993;148:15761580.
26. Hovestadt A, Bogaard JM, Meerwaldt JD, van der Meche FG,
Stigt J. Pulmonary function in Parkinsons disease. J Neurol
Neurosurg Psychiatry 1989;52:329333.
27. Polatli M, Akyol A, Cildag O, Bayulkem K. Pulmonary function
tests in Parkinsons disease. Eur J Neurol 2001;8:341345.
28. Selley WG, Flack FC, Ellis RE, Brooks WA. Respiratory patterns
associated with swallowing: Part 1. The normal adult pattern and
changes with age. Age Ageing 1989;18:168172.
29. Martin-Harris B, Brodsky MB, Price CC, Michel Y, Walters B.
Temporal coordination of pharyngeal and laryngeal dynamics
with breathing during swallowing: single liquid swallows. J Appl
Physiol 2003;94:17351743.
30. Klahn MS, Perlman AL. Temporal and durational patterns associating respiration and swallowing. Dysphagia 1999;14:131138.
31. Martin-Harris B, Brodsky MB, Michel Y, Ford CL, Walters B,
Heffner J. Breathing and swallowing dynamics across the adult
lifespan. Arch Otolaryngol Head Neck Surg 2005;131:762770.
32. Martin BJ, Logemann JA, Shaker R, Dodds WJ. Coordination
between respiration and swallowing: respiratory phase relationships and temporal integration. J Appl Physiol 1994;76:714723.
33. Palmer JB, Hiiemae KM. Eating and breathing: interactions
between respiration and feeding on solid food. Dysphagia
2003;18:169178.
34. Morton R, Minford J, Ellis R, Pinnington L. Aspiration with
dysphagia: the interaction between oropharyngeal and respiratory
impairments. Dysphagia 2002;17:192196.
35. Pinnington LL, Muhiddin KA, Ellis RE, Playford ED. Noninvasive assessment of swallowing and respiration in Parkinsons
disease. J Neurol 2000;247:773777.
123
58.
59.
60.
61.
62.
63.
64.
145
65. Deane KH, Whurr R, Clarke CE, Playford ED, Ben-Shlomo Y.
Non-pharmacological therapies for dysphagia in Parkinsons
disease. Cochrane Database Syst Rev 2001;CD002816.
66. Sharkawi AE, Ramig L, Logemann JA, Pauloski BR, Rademaker
AW, Smith CH, Pawlas A, Baum S, Werner C. Swallowing and
voice effects of Lee Silverman Voice Treatment (LSVT): a pilot
study. J Neurol Neurosurg Psychiatry 2002;72:3136.
67. Ramig LO, Countryman S, OBrien C, Hoehn M, Thompson L.
Intensive speech treatment for patients with Parkinsons disease:
short-and long-term comparison of two techniques. Neurology
1996;47:14961504.
68. Kijima M, Isono S, Nishino T. Coordination of swallowing
and phases of respiration during added respiratory loads in
awake subjects. Am J Respir Crit Care Med 1999;159:1898
1902.
Roxann Diez Gross PhD
Charles W. Atwood Jr. MD
Sheryl B. Ross MA
Kimberly A. Eichhorn MS
Joan W. Olszewski MA
Patrick J. Doyle PhD
123
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.